Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal in dialysis patients

Nephrology Dialysis Transplantation

Volumn 18, Issue 7, 2003, Pages 1388-1391

  Šabovi, Mišo ^a   Lavre, Janez ^b   Vujkovac, Bojan ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b Slovenj Gradec General Hospital   (Slovenia)

Author keywords

Dialysis; Erosive gastritis; Re bleeding; Tranexamic acid; Treatment; Upper gastrointestinal bleeding

Indexed keywords

ACETYLSALICYLIC ACID; ANTACID AGENT; ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; TRANEXAMIC ACID;

ADJUVANT THERAPY; ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG USE; ENDOSCOPIC SCLEROTHERAPY; FEMALE; GASTROINTESTINAL SURGERY; HEMODIALYSIS PATIENT; HUMAN; MALE; MEDICAL DECISION MAKING; PILOT STUDY; PRIORITY JOURNAL; STANDARD; TIME; TREATMENT OUTCOME; UPPER GASTROINTESTINAL BLEEDING; VEIN THROMBOSIS;

EID: 0037677083     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg117     Document Type: Article

References (17)

1. Doherty CC. Gastrointestinal bleeding in dialysis patients. Nephron 1993; 63: 132-139
2. Zuckerman GR, Cornette GL, Clouse RE, Harter HR. Upper gastrointestinal bleeding in patients with chronic renal failure. Ann Intern Med 1985; 102: 588-592
3. Milito G, Taccone-Gallucci M, Brancaleone C et al. The gastrointestinal tract in uremic patients on long-term hemodialysis. Kidney Int 1985; 28 [Suppl 17]: 157-160
4. Mannucci PM. Drug therapy: hemostatic drugs. N Engl J Med 1998; 339: 245-253
5. Mezzano D, Munoz B, Pais E, Downey P, Pereira J. Fast decrease of bleeding time by tranexamic acid in uremia. Thromb Haemost 2000; 83: 785.
6. Mezzano D, Tagle R, Panes O et al. Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis. Thromb Haemost 1996; 76: 312-321
7. Mezzano D, Panes O, Munoz B et al. Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure. Thromb Haemost 1999; 82: 1250-1254
8. Kozek-Langenecker SA, Masaki T, Mohammad H, Green W, Mohammad SF, Cheung AK. Fibrinogen fragments and platelet dysfunction in uremia. Kidney Int 1999; 56: 299-305
9. Vujkovac B, Lavre J, Šabovič M. Successful treatment of bleeding from colonic angiodysplasias with tranexamic acid in a hemodialysis patient. Am J Kidney Dis 1998; 31: 536-538
10. Vujkovac B, Šabovič M. Treatment of subdural and intracerebral hematomas in a hemodialysis patient with tranexamic acid. Nephrol Dial Tranplant 2000; 15: 107-109
11. Henry DA, O'Connell D. Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage. Br Med J 1989; 298: 1142-1146
12. Hawkey GM, Cole AT, McIntyre AS, Long RG, Hawkey CJ. Drug treatment in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut 2001; 49: 372-379
13. Cook DJ, Fuller HD, Guyatt GH et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994; 330: 377-381
14. Andersson L, Eriksson O, Hedlund PO, Kjelmann H, Lindqvist B. Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases. Urol Res 1978; 6: 83-88
15. Cox HT, Poller L, Thomson JM. Gastric fibrinolysis: a possible aetiological link with peptic ulcer. Lancet 1967; i: 1300-1302
16. Low J, Dodds AJ, Biggs JC. Fibrinolytic activity of gastroduodenal secretions - a possible role in upper gastrointestinal hemorrhage. Thromb Res 1980; 17: 819-830
17. Lindoff C, Rybo G, Astedt B. Treatment with tranexamic acid during pregnancy and the risk of thromboembolic complications. Thromb Haemost 1993; 70: 238-240